ERICA EDGE: Open Payments
NPI 1730756263 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,324 in 43 payments from 18 companies in 2025. Trend: 2023 $721 · 2024 $2,155 · 2025 $2,324
Food & beverage: $2,324
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $426 |
| AstraZeneca Pharmaceuticals LP | 3 | $237 |
| Exact Sciences Corporation | 4 | $219 |
| Lilly USA, LLC | 5 | $213 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $186 |
| Arcutis Biotherapeutics, Inc. | 3 | $152 |
| Astellas Pharma US Inc | 2 | $148 |
| Medtronic, Inc. | 3 | $138 |
| GlaxoSmithKline, LLC. | 1 | $123 |
| GENZYME CORPORATION | 1 | $111 |
Products named: Wegovy, Kerendia, Zoryve, Ozempic, Veozah, AIRSUPRA, INCEPTIV, AREXVY.
Industry payments across VA — which companies pay providers there.
